---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-003142"
form_type: "8-K"
ticker: "DMAC"
cik: "0001401040"
company_name: "DiaMedica Therapeutics Inc."
filed_at: "2022-02-11T23:59:59+00:00"
generated_at: "2026-06-27T08:42:49.162625+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# DiaMedica sets May 18, 2022 for annual meeting; shareholder proposal deadline March 4, 2022

## Summary
- Annual general meeting scheduled for May 18, 2022; date changed by more than 30 days from last year.
- Proxy materials expected to be printed March 30 and sent to shareholders around April 5, 2022.
- Shareholder proposals for inclusion in proxy must be received by March 4, 2022.

## SEC filing metadata
- accession: 0001437749-22-003142
- form_type: 8-K
- ticker: DMAC
- cik: 0001401040
- company_name: DiaMedica Therapeutics Inc.
- filed_at: 2022-02-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401040/000143774922003142/0001437749-22-003142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401040/000143774922003142/dmtp20220211_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-003142
- JSON: https://secwatch.observer/filing/0001437749-22-003142.json
- Plain text: https://secwatch.observer/filing/0001437749-22-003142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.